Viemed Healthcare, Inc.
General ticker "VMD" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $293.2M (TTM average)
Viemed Healthcare, Inc. follows the US Stock Market performance with the rate: 44.0%.
Estimated limits based on current volatility of 1.6%: low 11.91$, high 12.29$
Factors to consider:
- Total employees count: 1179 (+18.4%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Regulatory and compliance, Litigation risks, Supply chain disruptions, Acquisition/divestiture risks
- Current price 19.6% above estimated high
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.07$, 10.16$]
- 2026-12-31 to 2027-12-31 estimated range: [6.68$, 11.05$]
Financial Metrics affecting the VMD estimates:
- Positive: with PPE of 20.0 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 18.04 > 12.93
- Positive: 7.57 < Operating profit margin, % of 7.66
- Negative: Investing cash flow per share per price, % of -17.44 <= -14.27
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.17 > 6.02
- Positive: Shareholder equity ratio, % of 71.07 > 64.23
- Negative: 0 < Industry inventory ratio change (median), % of 0.25
Short-term VMD quotes
Long-term VMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $182.36MM | $226.16MM | $272.52MM |
| Operating Expenses | $168.03MM | $208.26MM | $249.57MM |
| Operating Income | $14.33MM | $17.90MM | $22.95MM |
| Non-Operating Income | $0.06MM | $-1.73MM | $-1.18MM |
| Interest Expense | $0.42MM | $0.78MM | $1.18MM |
| R&D Expense | $2.78MM | $3.07MM | $3.02MM |
| Income(Loss) | $14.39MM | $16.17MM | $21.77MM |
| Taxes | $4.15MM | $4.76MM | $6.39MM |
| Net Income(Loss)* | $10.24MM | $11.27MM | $14.93MM |
| Stockholders Equity | $113.89MM | $131.39MM | $141.54MM |
| Inventory | $4.63MM | $4.32MM | $5.05MM |
| Assets | $154.90MM | $177.07MM | $199.15MM |
| Operating Cash Flow | $45.21MM | $39.09MM | $51.92MM |
| Capital expenditure | $26.09MM | $37.77MM | $39.98MM |
| Investing Cash Flow | $-52.11MM | $-30.70MM | $-50.17MM |
| Financing Cash Flow | $2.83MM | $-3.69MM | $-5.79MM |
| Earnings Per Share** | $0.27 | $0.29 | $0.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.